Viatris Inc.
NASDAQ:VTRSDrug Manufacturers - Specialty & Generic
-$0.36 today
- Market cap
- $23.25B
- Beta
- 0.90
- P/E (TTM)
- -59.9
- EPS (TTM)
- -$0.26
- Dividend yield
- 3.12%
Volume 13.21M
Average 10.58M
VTRS Net Income
Bottom-line profit after all expenses, interest, and taxes.
Viatris Inc.NASDAQ: VTRS
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income remains negative
Q2 FY2026 net income was -$118.8M, compared with -$4.6M a year earlier. Trailing-twelve-month net income was -$410.7M.
Context
- Net income amounted to 24.6% of revenue in FY2025, up 20.3 pp from a year earlier.
- Net income increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of $3.03B (+186.1%) for the fiscal year ending Dec 2026, a step up from the -454.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -$118.8M-167.3% QoQ
- Last fiscal yearDec 2025
- -$3.51B-454.2% YoY
- LTMJun 2026
- -$410.7M+88.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -2482.6% | +670.4% | +3153.0 pp |
| 1 year | -454.2% | +186.1% | +640.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- (3.51B) USD
- Year-over-year change
- -454.2%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.51B) | -454.2% |
| FY2024 | 2024-12-31 | (634.2M) | -1259.4% |
| FY2023 | 2023-12-31 | 54.7M | -97.4% |
| FY2022 | 2022-12-31 | 2.08B | +263.8% |
| FY2021 | 2021-12-31 | (1.27B) | — |
Net Income vs competitors
How VTRS compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +88.2% is the 4th highest of 9, against a peer median of -48.1%.
- Net income amounts to 2.8% of revenue for VTRS, versus a peer median of 8.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | ₹28.03B INR | -52.2% | +0.0% | 8.5% | |
| LTM Jun 2025 | £2.41B GBP | — | +15.4% | 14.6% | |
| LTM Jun 2026 | $706M USD | +546.8% | — | 4.1% | |
| LTM Sep 2026 | $213M USD | -57.5% | -41.1% | 3.5% | |
| LTM Jun 2026 | $157.36M USD | +4562.6% | — | 5.0% | |
| LTM Mar 2026 | $89.67M USD | +526.0% | — | 9.7% | |
| LTM Mar 2026 | $79.23M USD | -44.1% | +2.4% | 11.0% | |
| LTM Sep 2026 | -$351K USD | -100.1% | — | 0.0% | |
| LTM Jun 2026 | -$410.7M USD | +88.2% | — | 2.8% | |
| LTM Jun 2026 | -$1.1B USD | -1220.4% | — | 10.1% | |
| Peer median (excluding VTRS) | — | -48.1% | +1.2% | 8.5% | |
Competitors are the stored peer set for VTRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.89B | 16.26B | 15.43B | 14.74B | 14.3B |
| Cost of Revenue | 12.31B | 9.77B | 8.99B | 9.12B | 9.29B |
| Gross Profit | 5.58B | 6.5B | 6.44B | 5.62B | 5.01B |
| Gross Margin | 31.2% | 40.0% | 41.7% | 38.2% | 35.1% |
| Research & Development | 681M | 662.2M | 805.2M | 808.7M | 965.9M |
| Selling, General & Admin | 4.53B | 4.18B | 4.65B | 4.43B | 3.79B |
| Operating Expenses | 5.61B | 4.88B | 5.67B | 5.61B | 7.68B |
| Depreciation & Amortization | 4.51B | 3.03B | 2.74B | 2.71B | 2.8B |
| EBITDA | 4.48B | 6.43B | 3.52B | 2.64B | (395.4M) |
| EBITDA Margin | 25.0% | 39.6% | 22.8% | 17.9% | -2.8% |
| Operating Income | (34M) | 1.61B | 766.2M | 10.1M | (2.66B) |
| Operating Margin | -0.2% | 9.9% | 5.0% | 0.1% | -18.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 636.2M | 592.4M | 573.1M | 550M | 471.3M |
| Other Income / Expenses | (630.4M) | 1.2B | (563.3M) | (633.3M) | (1B) |
| Income Before Tax | (664.4M) | 2.81B | 202.9M | (623.2M) | (3.67B) |
| Pre-Tax Margin | -3.7% | 17.3% | 1.3% | -4.2% | -25.6% |
| Income Tax Expense | 604.7M | 734.6M | 148.2M | 11M | (150.1M) |
| Net Income | (1.27B) | 2.08B | 54.7M | (634.2M) | (3.51B) |
| Net Margin | -7.1% | 12.8% | 0.4% | -4.3% | -24.6% |
| EPS (Basic) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| EPS (Diluted) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| Weighted Avg Shares | 1.21B | 1.21B | 1.2B | 1.19B | 1.17B |
| Weighted Avg Shares (Diluted) | 1.21B | 1.22B | 1.21B | 1.19B | 1.17B |
Viatris Inc.
NASDAQ:VTRS
Intrinsic Alpha fair value
Locked
Current Price
$20.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.